Drugs and toxic-associated pulmonary arterial hypertension, prognosis and management in the current era of treatment: results from the REHAP registry - Amsterdam 2025

Pulmonary arterial hypertension: imaging, biomarkers, physiological parameters and their impact on prognosis

Chair(s): David Montani, Sonia Schneer

Session type: Poster session

Drugs and toxic-associated pulmonary arterial hypertension, prognosis and management in the current era of treatment: results from the REHAP registry

Laura Lago Lagunas

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Cardiopulmonary hemodynamic determinants of long-term survival in sickle cell disease: insights from the ETENDARD study

Laurent Savale

Poster

Abstract

Peripheral microvascular endothelial function in pulmonary arterial hypertension.

Ricardo Jose Aguilar Colindres

Poster

Abstract

Survival predictors by race and ethnicity in pulmonary arterial hypertension

Rodney J. Folz

Poster

Abstract

The effect of co-morbidity on treatment response and survival in patients with idiopathic pulmonary arterial hypertension in Scotland

Greg Bear

Poster

Abstract

The functional roles of peripheral blood mononuclear cells in pulmonary hypertension

Shun Sato

Poster

Abstract

Effect of Eccentric Cycling on Cerebral and Muscle Near-Infrared Spectroscopy in Patients with Pulmonary Hypertension and Healthy Individuals. A Randomized Controlled Crossover Trial.

Julian Müller

Poster

Abstract

Mortality of patients with pulmonary arterial hypertension in france: a nationwide study

Charifa Nazoiri

Poster

Abstract

Strain-based right ventricular-pulmonary arterial coupling: Association with long-term mortality in pre-capillary pulmonary hypertension

Garvan Kane

Poster

Abstract

Clinical outcomes of Pulmonary Arterial Hypertension with Iron Deficiency In King Chulalongkorn Memorial Hospital

Noppharut Yutthana

Poster

Abstract

Drugs and toxic-associated pulmonary arterial hypertension, prognosis and management in the current era of treatment: results from the REHAP registry

Laura Lago Lagunas

Poster

Abstract

Inflammation and obesity correlate in pulmonary hypertension but associate with diverging outcomes

Eckart De Bie

Poster

Abstract

Rethinking Normal: eRVSP Below 35mmHg and Mortality Risk

Inbal Shafran

Poster

Abstract

Noninvasive screening for surgery in congenital heart disease

Jian Guo

Poster

Abstract

Association of subclinical lung disease on HRCT with outcomes in pulmonary arterial hypertension

Justine Tin Nok Chan

Poster

Abstract

Does mild to moderate pulmonary hypertension influence liver transplant outcomes?

Syed Murtaza Hassan Kazmi

Poster

Abstract

Pulmonary hypertension in patients with Noonan syndrome

Julien Grynblat

Abstract

From sit to stand: A simple test predicts adverse outcomes in pulmonary hypertension

Christina Kronberger

Poster

Abstract

Atrial and Brain Natriuretic Peptides Expression and Release in Right Heart Failure

Jessie Van Wezenbeek

Poster

Abstract

Unaffected carriers of a pathogenic BMPR2 variant exhibit a distinct pro-inflammatory cytokine profile despite the absence of disease

Eszter Nóra Tóth

Poster

Abstract

Long-term survival in idiopathic versus connective tissue disease-associated pulmonary hypertension; Croatian registry data

Marko Banic

Poster

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}